AgeX Therapeutics, Inc.·4

Jun 23, 9:46 PM ET

MAY MICHAEL H 4

4 · AgeX Therapeutics, Inc. · Filed Jun 23, 2021

Insider Transaction Report

Form 4
Period: 2021-06-21
Transactions
  • Award

    Option to Purchase Common Stock

    2021-06-21+35,00035,000 total
    Exercise: $1.48From: 2021-06-21Exp: 2031-06-20Common Stock (35,000 underlying)
  • Award

    Option to Purchase Common Stock

    2021-06-21+65,00065,000 total
    Exercise: $1.48Exp: 2031-06-20Common Stock (65,000 underlying)
Footnotes (1)
  • [F1]Options will vest and become exercisable in four equal quarterly installments on June 30, 2021, September 30, 2021, December 31, 2021, and March 31, 2022, provided that the grantee remains a director on the last day of the applicable calendar quarter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION